MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

OncoGenex Pharmaceuticals Company Profile (NASDAQ:OGXI)

Consensus Ratings for OncoGenex Pharmaceuticals (NASDAQ:OGXI) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.33 (233.33% upside)

Analysts' Ratings History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
Show:
DateFirmActionRatingPrice TargetActions
1/22/2016Needham & Company LLCLower Price TargetBuy$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2016RBC CapitalLower Price TargetSector Perform$1.60 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2015William BlairReiterated RatingBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/11/2016        
5/12/2016Q116($0.12)($0.12)$4.09 million$2.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q4($0.15)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2015Q3($0.17)($0.16)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2015Q2$0.34($0.26)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2015Q115($0.34)($0.20)$4.66 million$1.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/26/2015Q414($0.30)($0.27)$4.30 million$5.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014($0.38)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014($0.55)($0.47)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014($0.50)($0.59)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2014Q113($0.66)($0.45)$10.20 million$8.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.49)($0.40)$4.52 million$6.57 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.07)($0.07)($0.07)
Q2 20161($0.27)($0.27)($0.27)
Q3 20161($0.28)($0.28)($0.28)
Q4 20161($0.28)($0.28)($0.28)
(Data provided by Zacks Investment Research)
Dividend History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/13/2016Cindy JacobsCMOSell1,437$1.03$1,480.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2016Scott Daniel CormackCEOSell4,856$1.03$5,001.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Cindy JacobsCMOSell3,254$0.83$2,700.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016John BencichCFOSell834$0.83$692.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Scott Daniel CormackCEOSell12,033$0.83$9,987.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015John BencichCFOSell1,427$2.76$3,938.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Cindy JacobsCMOSell1,408$2.69$3,787.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Scott Daniel CormackCEOSell4,571$2.69$12,295.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Cindy JacobsCMOSell2,092$1.88$3,932.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Scott Daniel CormackCEOSell7,543$1.88$14,180.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Cindy JacobsCMOSell5,650$3.17$17,910.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Scott Daniel CormackCEOSell18,341$3.17$58,140.97View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Cindy JacobsCMOSell1,250$12.25$15,312.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Scott Daniel CormackCEOSell4,634$12.25$56,766.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Cindy JacobsCMOSell1,364$8.68$11,839.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Scott Daniel CormackCEOSell3,112$8.68$27,012.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2013Scott Daniel CormackCEOSell2,134$11.90$25,394.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2012Jack GoldsteinDirectorBuy1,000$14.38$14,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
DateHeadline
06/29/16 05:31 PMOncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Shorts Decreased by 16.46% After Short Covering - Engelwood Daily
06/29/16 05:31 PMCovering the Bases on OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI): Where is the Stock Going? - Press Telegraph
06/28/16 02:52 PMForget Valeant, Invest in These Attractive Drug Stocks Instead -
06/27/16 05:36 PMNext Weeks Broker Price Targets For OncoGenex Pharmaceuticals Inc. (OGXI) - Fiscal Standard
06/24/16 05:36 PMNew Broker Ratings For OncoGenex Pharmaceuticals Inc. (OGXI) - FTSE News
06/23/16 08:18 AMOncoGenex Pharmaceuticals Inc. (OGXI) Current Analyst Ratings - Fiscal Standard
06/20/16 07:01 AMONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events -
06/07/16 05:51 PMTwo Stocks within Traders Observation: Minerva Neurosciences, Inc (NASDAQ:NERV) , OncoGenex Pharmaceuticals ... - Street Updates
06/06/16 05:32 PMOncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) Earns Consensus Hold Rating - iStreetWire
06/06/16 09:19 AMOncoGenex Pharmaceuticals Inc. (OGXI) Broker Price Targets For The Coming Week - Share Trading News
06/03/16 06:06 PMBiotech Stocks within Assessment: MannKind Corporation (NASDAQ:MNKD) , OncoGenex Pharmaceuticals Inc ... - Is stories
06/03/16 02:32 PMETF’s with exposure to OncoGenex Pharmaceuticals, Inc. : June 3, 2016 -
06/02/16 05:59 PMBuy, Sell Or Hold Rating For OncoGenex Pharmaceuticals Inc. (OGXI)? - Share Trading News - Buy, Sell Or Hold Rating For OncoGenex Pharmaceuticals Inc. (OGXI)?Share Trading NewsOncoGenex Pharmaceuticals Inc. has a 50 day moving average of 0.93 and a 200 day moving average of 1.00. The stock's market capitalization is 31.41M, it has a 52-week low of 0.46 and a 52-week high of 4.10. The share price of the company (OGXI) was ...Tracking Unusual Volume for: OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI)Franklin IndependentOncoGenex Pharmaceuticals Inc. (OGXI) Analyst ReviewRisers & FallersTop Stock in Session: OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI)The PostNews Tribuneall 5 news articles »
06/01/16 05:06 AMONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters -
05/27/16 10:38 PMOncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) Closes At $1.0000 - Investor Newswire - OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) Closes At $1.0000Investor NewswireThe technical analysis of OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) stock highlights the stock is $0.0607 points away +6.7064% from its 50-day MA of $0.9044. It is $-0.0849 or -8.0857% away $1.0500, the 200-day Moving Average (MA) of stock.and more »
05/25/16 05:14 PMOncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Shorted Shares Increased By 35.48% - Wall Street Hints and News - Oncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Shorted Shares Increased By 35.48%Wall Street Hints and NewsThe short interest to Oncogenex Pharmaceuticals Incorporated's float is 3.92%. The stock is down 1.60% or $0.016 after the news, hitting $0.955 per share. About 639,680 shares traded hands. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) has declined ...
05/23/16 05:17 PMTraders Are Watching: Kornit Digital Ltd. (NASDAQ:KRNT), OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI ... - KC Register - Traders Are Watching: Kornit Digital Ltd. (NASDAQ:KRNT), OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI ...KC RegisterOncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced its first quarter 2016 financial results and provided a summary of anticipated milestones. Revenue for the three months ended March 31, 2016 and 2015 was $2.9 million and $1.4 million, ...and more »
05/21/16 08:37 AMRevenue Update on OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI) - Trade Calls - Revenue Update on OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI)Trade CallsOncoGenex Pharmaceuticals Inc(NASDAQ:OGXI) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 12, 2016. Company reported revenue of $2.94M. Analysts estimated a revenue of $4.09M.Oncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Shorted Shares Increased 35.48% After Market SellingWall Street Hints and Newsall 3 news articles »
05/20/16 10:21 PMOncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Shorted Shares Increased 35.48% After Market Selling - Wall Street Hints and News - Oncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Shorted Shares Increased 35.48% After Market SellingWall Street Hints and NewsThe short interest to Oncogenex Pharmaceuticals Incorporated's float is 3.92%. The stock decreased 0.56% or $0.005 on May 20, hitting $0.89. About 147,286 shares traded hands. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) has declined 56.94% ...
05/19/16 06:48 PMETF’s with exposure to OncoGenex Pharmaceuticals, Inc. : May 19, 2016 -
05/17/16 02:34 PMOncoGenex Pharmaceuticals, Inc. :OGXI-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/13/16 05:32 PMLatest Analyst Ratings For OncoGenex Pharmaceuticals Inc. (OGXI) - Share Trading News - Latest Analyst Ratings For OncoGenex Pharmaceuticals Inc. (OGXI)Share Trading NewsOncoGenex Pharmaceuticals Inc. has a 50 day moving average of 0.85 and a 200 day moving average of 1.14. The stock's market capitalization is 24.74M, it has a 52-week low of 0.46 and a 52-week high of 4.10. The share price of the company (OGXI) was ...OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016PR Newswire (press release)OncoGenex Pharmaceuticals' (OGXI) CEO Scott Cormack on Q1 2016 Results - Earnings Call TranscriptSeeking Alphaall 3 news articles »
05/13/16 03:52 AMOncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016 - PR Newswire (press release) - OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016PR Newswire (press release)Based on current expectations, OncoGenex believes that its cash, cash equivalents, and short-term investments will be sufficient to fund its currently planned operations into the third quarter of 2017. Depending on timing of enrollment or event-driven ...OncoGenex Pharmaceuticals' (OGXI) CEO Scott Cormack on Q1 2016 Results - Earnings Call TranscriptSeeking Alphaall 2 news articles »
05/12/16 06:18 PMEdited Transcript of OGXI earnings conference call or presentation 12-May-16 8:30pm GMT -
05/12/16 04:27 PMOncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016 - [at noodls] - May 12, 2016 BOTHELL, Wash. and VANCOUVER, British Columbia, May 12, 2016 /CNW/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced its first quarter 2016 financial results and provided a ...
05/12/16 03:12 PM4:12 pm OncoGenex Pharma reports Q1 EPS of ($0.12) vs ($0.12) Capital IQ Consensus Estimate; revs 111.1% y/y to $2.9 mln vs $4.1 mln Captial IQ Consensus Estimate. -
05/12/16 06:07 AMQ1 2016 OncoGenex Pharmaceuticals Inc Earnings Release - After Market Close -
05/10/16 05:33 PMConsensus Rating Review for OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) - B.O.D.Y Confidential - Consensus Rating Review for OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1 on shares of OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy, ...and more »
05/10/16 05:33 PMBuy Recommendations Count For OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) At 0 - Stocks Daily - NewsWay 21Buy Recommendations Count For OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) At 0Stocks DailyZacks rating methodology assigns scores to companies on a simplified 1-5 scale. A score towards the 1-2 band indicates a Buy call, 3 score implies a Hold while a rating of 4 or 5 denotes Sell call. Each brokerage group has its own way of assigning ...OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) Company Ratings ViewThe Postall 63 news articles »
05/09/16 05:27 PMHave a look at Price Moves: OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) , Sage Therapeutics, Inc. (NASDAQ ... - Street Updates - Have a look at Price Moves: OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) , Sage Therapeutics, Inc. (NASDAQ ...Street UpdatesOn 5/6/2016, OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) ended trading session lower at $0.95 with -2.06%. The company traded a volume of 638.74 thousand shares as comparison to average volume of 469.19 thousand shares. During the 52 –week ...
05/08/16 05:42 PMNext Weeks Broker Price Targets For OncoGenex Pharmaceuticals Inc. (OGXI) - Share Trading News - Next Weeks Broker Price Targets For OncoGenex Pharmaceuticals Inc. (OGXI)Share Trading NewsOncoGenex Pharmaceuticals Inc. has a 50 day moving average of 0.84 and a 200 day moving average of 1.17. The stock's market capitalization is 28.31M, it has a 52-week low of 0.46 and a 52-week high of 4.10. The share price of the company (OGXI) was ...
05/07/16 04:57 PMOncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Short Interest Decreased By 5.85% - B.O.D.Y Confidential - Oncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Short Interest Decreased By 5.85%B.O.D.Y ConfidentialOut of 4 analysts covering OncoGenex Pharma (NASDAQ:OGXI), 2 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 50% are positive. OncoGenex Pharma has been the topic of 6 analyst reports since August 17, 2015 according to StockzIntelligence Inc.and more »
05/05/16 05:49 PMEarnings Outlook on OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) - B.O.D.Y Confidential - Earnings Outlook on OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI)B.O.D.Y ConfidentialAnalysts and investors will be anticipating OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI)'s next earnings release which is expected to be posted on or around 2016-05-12. Sell-side research firms on Wall Street are expecting that the company will post ...and more »
05/04/16 05:31 PMEarnings in Focus: OncoGenex Pharmaceuticals (OGXI) - News Oracle - Earnings in Focus: OncoGenex Pharmaceuticals (OGXI)News OracleLast Trade: The Company rose 12.08% and finished at $1.02. The daily volume was measured at 1.19 million shares. The 52-week high of the share price is $4.10 and the 52-week low is $0.46. The company has a market cap of $28.39 million. Its latest ...and more »
05/04/16 05:31 PMInvestors Reviewing Stocks: OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) , Lexicon Pharmaceuticals, Inc ... - Street Updates - Investors Reviewing Stocks: OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) , Lexicon Pharmaceuticals, Inc ...Street UpdatesOn 5/3/2016, OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) ended trading session higher at $1.02 with +12.08%. The company traded a volume of 1.19 million shares as comparison to average volume of 447.08 thousand shares. During the 52 –week ...and more »
05/03/16 05:36 PMAverage Analyst Rating for OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) - B.O.D.Y Confidential - Average Analyst Rating for OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1 on OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks ...and more »
05/02/16 05:52 PMOncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Sellers Covered 5.85% of Their Shorts - B.O.D.Y Confidential - Oncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Sellers Covered 5.85% of Their ShortsB.O.D.Y ConfidentialOut of 4 analysts covering OncoGenex Pharma (NASDAQ:OGXI), 2 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 50% are positive. OncoGenex Pharma has been the topic of 6 analyst reports since August 17, 2015 according to StockzIntelligence Inc.
04/29/16 04:08 AMOverview of Price Moves: Sanofi (NYSE:SNY) , OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) - Street Updates - Overview of Price Moves: Sanofi (NYSE:SNY) , OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI)Street UpdatesOncoGenex Pharmaceuticals, Inc. (OGXI) reported that it will report its first quarter 2016 financial results on Thursday, May 12, 2016. Firm management will host a conference call and live webcast at 4:30 p.m. Eastern Time to provide an overview of ...OncoGenex Pharmaceuticals Inc. (OGXI) Updated Broker Price TargetsShare Trading NewsStock Earnings per share Analysis: OncoGenex Pharmaceuticals (NASDAQ:OGXI)News Oracleall 5 news articles »
04/28/16 10:58 PMOncoGenex Pharmaceuticals Inc. (OGXI) Updated Broker Price Targets - Share Trading News - OncoGenex Pharmaceuticals Inc. (OGXI) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of OncoGenex Pharmaceuticals Inc. (OGXI). The latest reports which are currently in issue on Thursday 28th of April state 0 analysts have a rating of “strong buy”, 0 ...Stock EPS to Watch: OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)News Oracleall 3 news articles »
04/28/16 05:51 PMStock EPS to Watch: OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) - News Oracle - Stock EPS to Watch: OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)News OracleLast Trade: The Company rose 22.22% and finished at $1.32. The daily volume was measured at 12.51 million shares. The 52-week high of the share price is $4.10 and the 52-week low is $0.46. The company has a market cap of $49.42 million. Its latest ...and more »
04/28/16 05:51 PMHealthcare Stocks to watch: Abbott Laboratories (NYSE:ABT) , OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) - Is stories - Healthcare Stocks to watch: Abbott Laboratories (NYSE:ABT) , OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI)Is storiesIn most recently trading session on 4/27/2016, OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) dropped -15.91% while traded on 3.02 million shares versus it's an average volume of 352.71 thousand shares. The company recorded the last trade with the ...and more »
04/28/16 03:15 PMOncoGenex to Report First Quarter 2016 Financial Results on May 12, 2016 - [at noodls] - April 28, 2016 BOTHELL, Wash. and VANCOUVER, British Columbia, April 28, 2016 /CNW/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that it will report its first quarter 2016 financial ...
04/27/16 10:56 PMTrending Stocks in Focus: OncoGenex Pharmaceuticals (OGXI), Pernix Therapeutics Holdings (PTX) - News Oracle - Trending Stocks in Focus: OncoGenex Pharmaceuticals (OGXI), Pernix Therapeutics Holdings (PTX)News OracleOncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) surged 22.22% yesterday and closed at $1.32. The company's market capitalization is at $49.42 Million with an average trading volume of 178,763.00. The total number of Outstanding Shares Held by the ...and more »
04/27/16 05:47 PMStock Falling Today: OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - The Post - Stock Falling Today: OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI)The PostOncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) was a top loser in today's session as the company saw shares drop -15.14% on the day at the time of writing. Stocks whose market prices drop the most during the trading day are bluntly referred to as losers.
04/27/16 05:47 PMOncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) Wall Street Rating in Focus - News Tribune - OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 2 equity research firms that cover shares of OncoGenex Pharmaceuticals Inc.and more »
04/25/16 07:25 AM8 Breakout Stocks Under $10 to Trade for Big Profits -
03/29/16 10:03 AMETF’s with exposure to OncoGenex Pharmaceuticals, Inc. : March 29, 2016 -
03/17/16 08:58 AMETF’s with exposure to OncoGenex Pharmaceuticals, Inc. : March 17, 2016 -
03/16/16 09:52 AMOncoGenex Pharmaceuticals, Inc. :OGXI-US: Earnings Analysis: 2015 By the Numbers -
03/15/16 12:04 PMONCOGENEX PHARMACEUTICALS, INC. Financials -
About OncoGenex Pharmaceuticals

OncoGenex Pharmaceuticals logoOncoGenex Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of new therapies that address treatment resistance in cancer patients. The Company has three product candidates in its pipeline: custirsen, apatorsen and OGX-225. Of the product candidates in its pipeline, custirsen and apatorsen are clinical-stage assets being evaluated in two Phase III studies and five Phase II studies. These product candidates focus on mechanisms of treatment resistance in cancer patients and are designed to block the production of specific proteins that promote treatment resistance and survival of tumor cells and are over-produced in response to a variety of cancer treatments.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: OGXI
  • CUSIP: 68230A10
Key Metrics:
  • Previous Close: $1.04
  • 50 Day Moving Average: $1.01
  • 200 Day Moving Average: $0.88
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $31.11M
  • Current Quarter EPS Consensus Estimate: $-0.90 EPS
Additional Links:
OncoGenex Pharmaceuticals (NASDAQ:OGXI) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha